Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1

被引:72
作者
Ploplis, VA
Cornelissen, I
Sandoval-Cooper, MJ
Weeks, L
Noria, FA
Castellino, FJ
机构
[1] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
[2] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA
关键词
D O I
10.1016/S0002-9440(10)63949-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Clinical studies have indicated that high plasma levels of fibrinogen, or decreased fibrinolytic potential, are conducive to an increased risk of cardiovascular disease. Other investigations have shown that insoluble fibrin promotes atherosclerotic lesion formation by affecting smooth muscle cell proliferation, collagen deposition, and cholesterol accumulation. To directly assess the physiological impact of an imbalanced frbrinolytic system on both early and late stages of this disease, mite deficient for plasminogen activator inhibitor-1 (PAI-1(-/-)) were used in a model of vascular injury/repair, and the resulting phenotype compared to that of wild-type (WT) mice. A. copper-induced arterial injury was found to generate a lesion with characteristics similar to many of the clinical features of atherosclerosis, Fibrin deposition in the injured arterial wall at early (7 days) and late (21 days) times after copper cuff placement was prevalent in WT mice, but was greatly diminished in PAI-1(-/-) mice. A multilayered neointima with enhanced collagen deposition was evident at day 21 in WT mice. In contrast, only diffuse fibrin was identified in the adventitial compartments of arteries from PAI-1(-/-) mice, with no evidence of a neointima. Neovascularization was observed in the adventitia and was more extensive in WT arteries, relative to PAI-1(-/-) arteries. Additionally, enhanced PAI-1 expression and fat deposition were seen only in the arterial walls of WT mice. The results of this study emphasize the involvement of the fibrinolytic system in vascular repair processes after injury and indicate that alterations in the fibrinolytic balance in the vessel wall have a profound effect on the development and progression of vascular lesion formation.
引用
收藏
页码:107 / 117
页数:11
相关论文
共 60 条
[1]   Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells [J].
Allison, BA ;
Nilsson, L ;
Karpe, F ;
Hamsten, A ;
Eriksson, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) :1354-1360
[2]   OXYGEN RADICALS INHIBIT HUMAN PLASMA ACETYLHYDROLASE, THE ENZYME THAT CATABOLIZES PLATELET-ACTIVATING-FACTOR [J].
AMBROSIO, G ;
ORIENTE, A ;
NAPOLI, C ;
PALUMBO, G ;
CHIARIELLO, P ;
MARONE, G ;
CONDORELLI, M ;
CHIARIELLO, M ;
TRIGGIANI, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2408-2416
[3]  
Arza B, 1997, THROMB HAEMOSTASIS, V78, P1097
[4]   The urokinase receptor. A cell surface, regulated chemokine [J].
Blasi, F .
APMIS, 1999, 107 (01) :96-101
[5]   Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation - A gene targeting and gene transfer study in mice [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Janssens, S ;
Lupu, F ;
Collen, D ;
Gerard, RD .
CIRCULATION, 1997, 96 (09) :3180-3191
[6]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION [J].
CARMELIET, P ;
KIECKENS, L ;
SCHOONJANS, L ;
REAM, B ;
VANNUFFELEN, A ;
PRENDERGAST, G ;
COLE, M ;
BRONSON, R ;
COLLEN, D ;
MULLIGAN, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2746-2755
[7]  
Colli S, 1999, THROMB HAEMOSTASIS, V81, P576
[8]  
DANA K, 1994, FIBRINOLYSIS, V8, P189
[9]   Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? [J].
Deng, G ;
Curriden, SA ;
Wang, SJ ;
Rosenberg, S ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 1996, 134 (06) :1563-1571
[10]   Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells [J].
Dichtl, W ;
Stiko, A ;
Eriksson, P ;
Goncalves, I ;
Calara, F ;
Banfi, C ;
Ares, MPS ;
Hamsten, A ;
Nilsson, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :3025-3032